X

pharmaceuticals

Procter & Gamble Health Ltd Q3FY24; 6% fall in Profits

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing…

Alembic Pharmaceuticals Ltd Q3FY24; 48% rise in Profits

Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients.The…

Natco Pharma Ltd Q3FY24; 244% rise in Profits

NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing…

Marksans Pharma Ltd Q3FY24; 34% rise in Profits

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for…

GMM Pfaudler Ltd Q3FY24; 63% rise in Profits

GMM Pfaudler manufactures corrosion resistant glass-lined equipments . It is a leading supplier of process equipments to the pharmaceutical and…

Laurus Labs Ltd Q3FY24; 89% fall in Profits

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

Natco Pharma Ltd Q3 FY24 Earnings Conference Call Insights

Key highlights from Natco Pharma Ltd (NATCOPHARM) Q3 FY24 Earnings Concall Financial Performance Recorded total revenue of INR795.6 crores in…

Strides Pharma Science Ltd Q3FY24; 20% rise in Revenue

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are…

Jubilant Ingrevia Ltd Q3FY24; 58% fall in Profits

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers…

Divi’s Laboratories Ltd Q3 FY24 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY24 Earnings Concall Growth and Performance Witnessed a steady 3Q driven by…